Dianthus Therapeutics | MGTA - Trade Creditors

Stock Price
87.14
Daily Change
-0.26 -0.29%
Monthly
9.67%
Yearly
306.22%
Q2 Forecast
85.52

Dianthus Therapeutics reported $9.72M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Akebia Therapeutics USD 21.18M 11.1M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Avita Medical AUD 8.96M 1.69M Dec/2025
Celltrion KRW 104.19B 15.67B Sep/2025
Cspc Pharmaceutical CNY 2.32B 236.83M Dec/2025
Deva Holding AS TRY 809.81M 105.88M Sep/2023
Dianthus Therapeutics USD 9.72M 3.02M Dec/2025
Divis Laboratories Ltd INR 10.4B 1.3B Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Kangmei Pharma CNY 2.61B 176.42M Sep/2025
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Laboratorios Farma EUR 107.59M 341K Dec/2023
Malin Corporation EUR 700K 200K Dec/2024
Medical Developments International AUD 4.31M 2.18M Dec/2025
Moderna USD 317M 50M Dec/2025
Neuren Pharmaceuticals AUD 2.4M 4.26M Dec/2025
Organigram Holdings CAD 71.08M 18.17M Dec/2025
Organon & Co USD 1.07B 7M Sep/2025
Ovoca Bio EUR 186K 23K Jun/2025
Pharma Mar EUR 54.34M 10.54M Dec/2025
Qiagen NV USD 72.66M 2.11M Dec/2025
Revvity USD 185.46M 9.66M Dec/2025
Sartorius EUR 345.3M 2.2M Mar/2026
Sino Biopharmaceutical CNY 2.82B 1.32B Jun/2025
Tectonic Therapeutic USD 1.09M 392K Dec/2025
Tilray USD 114.5M 3.69M Sep/2025
Viatris USD 1.33B 6.4M Sep/2025
Xeris Pharmaceuticals USD 3.08M 3.45M Dec/2025
Zealand Pharma A/S 346.6M 102.71M Dec/2025
Zz Pientze Pharmaceu CNY 516.14M 31.53M Sep/2025